Document Detail

Curcumin Resistance Induced by Hypoxia in HepG2 Cells Is Mediated by Multidrug-resistance-associated Proteins.
MedLine Citation:
PMID:  23225435     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Tumor hypoxia, a common pathophysiological feature of solid tumors, contributes to drug resistance and treatment failure. Here, we demonstrate that hypoxia in HepG2 cells induces resistance towards cytotoxicity of curcumin, a promising anticancer agent.
MATERIALS AND METHODS: The number of surviving cells after exposure to chemotherapeutic drugs under normoxia (ambient O(2)) and hypoxia (1% O(2)) was determined by crystal violet staining. The expression levels of drug transporter genes were analyzed by quantitative real-time reverse transcription-polymerase chain reaction.
RESULTS: Increased resistance to curcumin, as well as to etoposide and doxorubicin, was observed in HepG2 cells under hypoxia. Gene expression analysis revealed that hypoxia increased the expression of ATP-binding cassette (ABC) drug transporter genes, sub-family C including ABCC1, ABCC2, and ABCC3, by more than two-fold. While expression of ABC drug transporter genes sub-family B member 1 and sub-family G member 2 (ABCB2/P-gp and ABCG2, respectively) did not change significantly. Both inhibitors of ABCC1/ABCC2 and depletion of intracellular glutathione levels were able to reverse hypoxia-induced curcumin resistance.
CONCLUSION: ABCC1 and ABCC2 play an important role in hypoxia-induced curcumin resistance in human hepatocellular carcinoma.
Titipatima Sakulterdkiat; Chantragan Srisomsap; Rachanee Udomsangpetch; Jisnuson Svasti; Kriengsak Lirdprapamongkol
Related Documents :
24016115 - Mechanism-based inhibition of cyp450: an indicator of drug-induced hepatotoxicity.
23486565 - A novel pulsed drug-delivery system: polyelectrolyte layer-by-layer coating of chitosan...
24616145 - Artificial bacterial flagella for remote-controlled targeted single-cell drug delivery.
24382825 - In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential dr...
11721645 - Progress in methodologies for evaluating bioequivalence of topical formulations.
16221375 - New agents in the treatment of childhood leukemias and myelodysplastic syndromes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  32     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  5337-42     Citation Subset:  IM    
Laboratory of Biochemistry, Chulabhorn Research Institute, 54 Kamphaeng Phet 6, Talat Bang Khen, Laksi, Bangkok 10210, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Studies on the Activity of Two Trans-Planaramine Platinum(II) Complexes Coded as DH4 and DH5 in Huma...
Next Document:  Artonin E Mediates MCL1 Down-regulation and Sensitizes Lung Cancer Cells to Anoikis.